1.
Dazdotuftide: Novel Treatment for Noninfectious Uveitis with Superior Intraocular Pressure Safety Profile: A Randomized Clinical Trial.
Chu David S, Tsui Edmund, Rifkin Lana M, Palestine Alan G, Rich Cadmus, Thorne Jennifer E et al.
Am J OphthalmolApr 20260 citationsRandomized Controlled Trial
Dazdotuftide showed noninferiority for uveitis flare/pain control versus prednisolone, with significantly fewer IOP elevations. This steroid-sparing option could benefit patients prone to steroid-induced IOP, despite less complete cell resolution.